#UTD1

Biostar Pharma's UTD1 Begins Pivotal Trial for Treating Brain Metastases from Breast Cancer Biostar Pharma's UTD1 has officially begun patient dosing in the U.S., marking a significant step in treating brain metastases in breast cancer.

Biostar Pharma's UTD1 Begins Pivotal Trial for Treating Brain Metastases from Breast Cancer #United_States #San_Francisco #Breast_Cancer #Biostar_Pharma #UTD1